News | May 29, 2023
Roquette, Beren Therapeutics join forces to advance cyclodextrin technologies
Aim of the agreement is to expand the full potential of Beren’s cyclodextrin technologies and their medicinal applications.
Aim of the agreement is to expand the full potential of Beren’s cyclodextrin technologies and their medicinal applications.
Product deliveries scheduled in Q3 of 2023
Lonza launches the TheraPEAK T-VIVO Cell Culture Medium with a novel chemically defined formulation developed to optimize and streamline CAR T-cell manufacturing
First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacement
Farxiga is expected to have such a strong influence on the market due to the impressive results
To enhance housing and enclosure design and performance for the Asia Pacific medical devices market, Kraiburg TPE offers the Thermoplast H HC/AP and HC/AD1/AP series
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
Lucid-MS is a new drug candidate for the treatment of multiple sclerosis
The company moves a step closer towards achieving its goal of emerging as the top oncology medicine supplier from India in the ASEAN region
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
Subscribe To Our Newsletter & Stay Updated
